TITLE

Recurrence of Venous Thromtoembolic Disease and Use of Oral Contraceptives

AUTHOR(S)
Badaracco, Mary A.; Vessey, Martin P.
PUB. DATE
February 1974
SOURCE
British Medical Journal;2/9/1974, Vol. 1 Issue 5901, p215
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64109535

 

Related Articles

  • WHO task force answers questions on oral contraceptive use.  // Public Health Reports;Jan/Feb96, Vol. 111 Issue 1, p4 

    Reports on a study by the World Health Organization (WHO) providing information on combined oral contraceptives that contain an estrogen and a progestogen and the risk of venous thromboembolism. Risk of ischemic stroke and venous thromboembolic disease for women using oral contraceptives;...

  • Comparing VTE risks of various hormone formulations.  // Contemporary OB/GYN;Jan2005, Vol. 50 Issue 1, p17 

    The article discusses a research which examined the risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy. The study compared venous thromboembolic events (VTE) between women who uses oral contraceptives (OC) and women who are nonusers. The...

  • Third generation oral contraceptives and risk of venous thromboembolic disorders: An... Spitzer, Walter O.; Lewis, Michael A. // BMJ: British Medical Journal (International Edition);1/13/96, Vol. 312 Issue 7023, p83 

    Presents the results of a study aimed at testing whether the use of combined oral contraceptives containing third generation progestogens is associated with altered risk of venous thromboembolism. Link between oral contraceptives and an increase in the incidence of vascular disease; Risk of...

  • Oral Contraceptives and the Risk of Venous Thrombosis. Vandenbroucke, Jan P.; Rosing, Jan; Bloemenkamp, Kitty W.M.; Middeldorp, Saskia; Helmerhorst, Frans M.; Bouma, Bonno N.; Rosendaal, Frits R. // New England Journal of Medicine;05/17/2001, Vol. 344 Issue 20, p1527 

    Reports on developments in the understanding of venous thrombosis resulting from oral contraceptive use. Risks associated with low-dose oral contraceptives; Possible effect of progestin on increased risk of venous thrombosis; The effect of progestins in combined preparations; Susceptibility to...

  • Contraceptives: VTE risk similar with transdermal and oral.  // Reactions Weekly;5/13/2006, Issue 1101, p3 

    The article discusses a case-control study which revealed that the risk of nonfatal venous thromboembolism (VTEs), a complex vascular disease with a multifactorial pathogenesis, appeared to be similar with either transdermal or oral contraceptive (OC) use.

  • Oral contraceptives and venous thromboembolism: findings in a large prospective study. Vessey, Martin; Mant, David; Smith, Alison; Yeates, David // British Medical Journal (Clinical Research Edition);2/22/1986, Vol. 292 Issue 6519, p526 

    Examines the association between oral contraceptives and venous thromboembolism. Calculation of age, smoking history and history of varicose veins; Positive correlation between contraceptives and thromboembolism; Absence of association between risk and duration of use of oral contraceptives.

  • Risk of VTE with Oral Contraceptives. Jensen, Jeffrey T. // OB/GYN Clinical Alert;Nov2009, Vol. 26 Issue 7, p52 

    The risk of venous thrombosis associated with oral contraceptive use correlated with ethinyl estradiol dose and was lowest in users of levonorgestrel combination pills.

  • Although safe, certain oral contraceptives confer increased risk for VTE.  // Hem/Onc Today;11/25/2011, Vol. 12 Issue 22, p31 

    The article presents a study that deals with the role of the use of oral contraceptives in increasing risk for venous thromboembolism.

  • Cyproterone with ethinylestradiol: risk of venous thromboembolism.  // WHO Drug Information;2002, Vol. 16 Issue 1, p27 

    Reports on the New Zealand Medicines Adverse Reactions Committee's (MARC) advice regarding the risk of venous thromboembolism with oral contraceptives containing cyproterone acetate and ethinylestradiol. Cases of venous thromboembolism in women taking cyproterone-ethinylestradiol pills; Use of...

  • Commentary. Lewis, Marcel // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p59 

    The article focuses on the contribution of male sex, oral contraception and first idiopathic deep venous thrombosis to recurrent venous thrombotic events. Contralateral recurrent thrombosis occurs less frequently than ipsilateral recurrent thrombosis. An initial presentation as pulmonary...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics